The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma
Clinical trial NCT04262427 · UNKNOWN
Trial details
- NCT number
- NCT04262427
- Sponsor
- The Christie NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2023-10-28
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.